HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gerald B Pier Selected Research

polysaccharide intercellular adhesin

4/2020Glycomics Microarrays Reveal Differential In Situ Presentation of the Biofilm Polysaccharide Poly-N-acetylglucosamine on Acinetobacter baumannii and Staphylococcus aureus Cell Surfaces.
1/2017A Novel Repressor of the ica Locus Discovered in Clinically Isolated Super-Biofilm-Elaborating Staphylococcus aureus.
5/2007Protection against Escherichia coli infection by antibody to the Staphylococcus aureus poly-N-acetylglucosamine surface polysaccharide.
10/2005Poly-N-acetylglucosamine production in Staphylococcus aureus is essential for virulence in murine models of systemic infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gerald B Pier Research Topics

Disease

62Infections
03/2022 - 02/2002
19Cystic Fibrosis (Mucoviscidosis)
11/2021 - 02/2002
17Pneumonia (Pneumonitis)
11/2021 - 07/2004
6Inflammation (Inflammations)
10/2012 - 03/2007
5Bacteremia
10/2017 - 04/2005
5Keratitis
12/2016 - 03/2008
5Pseudomonas Infections
10/2012 - 02/2002
5Lung Diseases (Lung Disease)
07/2012 - 02/2003
3Sepsis (Septicemia)
10/2019 - 05/2007
3Staphylococcal Infections
10/2015 - 05/2006
3Community-Acquired Infections
08/2012 - 02/2010
3Persistent Infection
06/2009 - 07/2003
3Neoplasms (Cancer)
02/2008 - 11/2003
2Peritonitis
04/2016 - 06/2012
2Bacterial Infections (Bacterial Infection)
07/2015 - 01/2013
2Necrotizing Pneumonia
07/2013 - 11/2010
2Soft Tissue Infections
07/2013 - 11/2010
2Neutropenia
01/2013 - 04/2005
2Corneal Ulcer
10/2012 - 10/2008
1Gonorrhea
03/2022
1Vector Borne Diseases
12/2021
1Babesiosis (Piroplasmosis)
12/2021
1Pathologic Neovascularization
11/2021
1COVID-19
11/2021
1Graft vs Host Disease (Graft-Versus-Host Disease)
10/2019
1Bacterial Conjunctivitis
01/2018
1Conjunctivitis
01/2018
1Atherosclerotic Plaque (Atheroma)
01/2017
1Osteomyelitis
01/2017
1Fungal Eye Infections
12/2016
1Mycoses (Diseases, Fungus)
12/2016
1Vaccine-Preventable Diseases
01/2016
1Cross Infection (Nosocomial Infection)
01/2015
1Glanders
01/2015
1Bronchiectasis
03/2014
1Eye Infections
07/2013
1Coinfection
06/2012

Drug/Important Bio-Agent (IBA)

17AntibodiesIBA
12/2021 - 07/2003
14VaccinesIBA
03/2022 - 02/2006
12Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA
10/2012 - 02/2002
10Polysaccharides (Glycans)IBA
01/2021 - 10/2005
8AntigensIBA
12/2021 - 02/2006
7poly-N-acetyl glucosamineIBA
11/2021 - 12/2016
7Monoclonal AntibodiesIBA
01/2018 - 11/2004
6CytokinesIBA
11/2021 - 10/2005
6Anti-Bacterial Agents (Antibiotics)IBA
10/2019 - 10/2008
6Immunoglobulin G (IgG)IBA
01/2018 - 05/2006
6AlginatesIBA
01/2018 - 11/2004
5Virulence Factors (Pathogenicity Factors)IBA
09/2013 - 10/2005
5Panton-Valentine leukocidinIBA
07/2013 - 02/2010
5Immune Sera (Antisera)IBA
12/2012 - 01/2012
5NF-kappa B (NF-kB)IBA
05/2010 - 01/2004
5LipopolysaccharidesIBA
10/2008 - 11/2003
4polysaccharide intercellular adhesinIBA
04/2020 - 10/2005
4Conjugate VaccinesIBA
01/2016 - 08/2011
3Interleukin-1 (Interleukin 1)IBA
11/2021 - 04/2007
3Immunoglobulins (Immunoglobulin)IBA
11/2021 - 05/2006
3Interleukin-17 (Interleukin 17)IBA
12/2016 - 10/2008
3Complement System Proteins (Complement)IBA
06/2013 - 05/2006
3EpitopesIBA
05/2006 - 11/2004
2Complement C1q (C1q Complement)IBA
01/2021 - 01/2021
2Capsules (Microcapsules)IBA
01/2019 - 04/2010
2Interleukin-22 (IL-22)IBA
12/2016 - 10/2015
2Proteins (Proteins, Gene)FDA Link
01/2016 - 02/2002
2OligosaccharidesIBA
01/2016 - 01/2004
2Biological ProductsIBA
01/2015 - 10/2012
2Therapeutic UsesIBA
12/2012 - 03/2010
2Membrane Proteins (Integral Membrane Proteins)IBA
10/2012 - 02/2006
2Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
10/2012 - 05/2010
2Interleukin-17 ReceptorsIBA
10/2012 - 10/2008
2FlagellinIBA
08/2011 - 02/2010
2Biomarkers (Surrogate Marker)IBA
05/2008 - 03/2007
2O Antigens (O Antigen)IBA
07/2004 - 11/2003
1SolutionsIBA
03/2022
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
11/2021
1Fibrin Fibrinogen Degradation ProductsIBA
11/2021
1Immunoglobulin Km AllotypesIBA
11/2021
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
11/2021
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2021
1Staphylococcal Protein A (Protein A)IBA
01/2021
1Glycoside Hydrolases (Endoglycosidases)IBA
01/2018
1Anti-Infective Agents (Microbicides)IBA
10/2017
1IronIBA
01/2016
1Shiga Toxin (Shigella Toxin)IBA
03/2014
1amelubantIBA
03/2014
1DNA (Deoxyribonucleic Acid)IBA
03/2014
1Leukotriene B4IBA
03/2014
1Opsonin Proteins (Opsonins)IBA
06/2013
1Ion Pumps (Ion Pump)IBA
01/2013
1Type V Secretion SystemsIBA
10/2012
1ChloridesIBA
10/2012
1Bicarbonates (Hydrogen Carbonate)IBA
10/2012
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2012
1Cytotoxins (Cytolysins)IBA
08/2012

Therapy/Procedure

6Therapeutics
10/2012 - 02/2003
5Immunotherapy
12/2016 - 02/2006
2Drug Therapy (Chemotherapy)
02/2008 - 04/2005
1Cell Transplantation
10/2019
1Intraperitoneal Injections
01/2018
1Knee Prosthesis
01/2017